Published in Can J Gastroenterol on September 01, 2012
Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review. World J Gastroenterol (2015) 0.78
Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32
Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant (2010) 2.02
Management of strictures of the biliary tract. Surg Clin North Am (1971) 2.02
Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67
Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl (2006) 1.60
Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl (2007) 1.50
Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg (2008) 1.49
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery (2009) 1.39
Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl (2008) 1.36
Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology (1993) 1.18
Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc (2007) 1.10
Biliary strictures in liver transplant recipients: treatment with metal stents. Radiology (1996) 1.07
Intrahepatic biliary strictures after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.05
Endoscopic management of biliary strictures in liver transplant recipients: effect on patient and graft survival. Gastrointest Endosc (1998) 1.04
Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts. Transplantation (2011) 1.03
Donation after cardiac death in the US: history and use. J Am Coll Surg (2006) 0.97
Endoscopic retrograde cholangiopancreatography in patients with biliary complications after orthotopic liver transplantation: outcomes and complications. Transplant Proc (2009) 0.97
Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc (2009) 0.91
Placement of removable metal biliary stent in post-orthotopic liver transplantation anastomotic stricture. World J Gastroenterol (2010) 0.88
Treatment of post liver transplantation bile duct stricture with self-expandable metallic stent. HPB (Oxford) (2006) 0.85
Effect of ERCP utilization and biliary complications on post-liver-transplantation mortality and graft survival. Dig Dis Sci (2010) 0.83
ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg (2014) 3.60
Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med (2005) 2.67
Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg (2002) 2.45
Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts. Liver Transpl (2013) 2.03
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology (2010) 2.02
Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg (2014) 1.69
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69
National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada. CMAJ (2006) 1.68
Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl (2005) 1.67
Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort. AIDS (2011) 1.61
Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol (2014) 1.59
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation (2004) 1.51
Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl (2013) 1.46
Canadian contribution to the ACS. Can J Surg (2013) 1.43
Management of umbilical hernia in patients with advanced liver disease. Liver Transpl (2003) 1.42
Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl (2004) 1.42
Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl (2007) 1.27
The Role 3 Multinational Medical Unit at Kandahar Airfield 2005-2010. Can J Surg (2011) 1.25
Percutaneous liver biopsy practice patterns among Canadian hepatologists. Can J Gastroenterol (2013) 1.15
Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience. Can J Anaesth (2011) 1.10
Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol (2002) 1.10
Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology (2002) 1.10
Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins. J Mol Recognit (2004) 1.09
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol (2011) 1.09
Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases. J Gastrointest Surg (2010) 1.03
The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation (2006) 1.03
Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts. Transplantation (2011) 1.03
Causes of death in Canadian Forces members deployed to Afghanistan and implications on tactical combat casualty care provision. J Trauma (2011) 1.02
Defining readmission risk factors for liver transplantation recipients. Gastroenterol Hepatol (N Y) (2011) 1.01
Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care (2008) 0.98
Acoustic deposition with NIMS as a high-throughput enzyme activity assay. Anal Bioanal Chem (2012) 0.96
Impact of hemochromatosis screening in patients with indeterminate results: the hemochromatosis and iron overload screening study. Genet Med (2006) 0.95
A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. PLoS One (2012) 0.94
Is Helicobacter pylori being treated appropriately? A study of inpatients and outpatients in a tertiary care centre. Can J Gastroenterol (2007) 0.91
Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. Can J Gastroenterol (2008) 0.91
Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl (2009) 0.91
Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry. Ann Surg (2015) 0.90
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Liver Transpl (2009) 0.89
1 Canadian Field Hospital in Haiti: surgical experience in earthquake relief. Can J Surg (2012) 0.87
Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study. Dig Dis Sci (2006) 0.86
Prospective evaluation of the role of quantitative Doppler ultrasound surveillance in liver transplantation. Liver Transpl (2004) 0.86
Elective and emergency abdominal surgery in patients 90 years of age or older. Can J Surg (2012) 0.86
Hepatic resection for huge (>15 cm) multinodular HCC with macrovascular invasion. J Surg Res (2012) 0.86
Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. Liver Transpl (2003) 0.85
ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors. Results of a Multicentre Analysis: Reply. World J Surg (2015) 0.83
Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program. CMAJ (2002) 0.83
Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation (2003) 0.83
Giant cystic pheochromocytoma containing high concentrations of catecholamines and metanephrines. J Clin Endocrinol Metab (2011) 0.82
Pharmacogenomics in liver transplantation. Liver Transpl (2003) 0.82
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. Transplantation (2006) 0.81
A point mutation in the iron-responsive element of the L-ferritin in a family with hereditary hyperferritinemia cataract syndrome. Can J Gastroenterol (2005) 0.81
Hepatic metastasis from adrenocortical carcinoma fifteen years after primary resection. Saudi J Gastroenterol (2012) 0.81
Anonymous pilot study of hepatitis C virus prevalence in liver transplant surgeons. Liver Transpl (2006) 0.81
A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma. World J Gastroenterol (2012) 0.80
Recipient ineligibility after liver transplantation assessment: a single centre experience. Can J Surg (2013) 0.80
Crystal structures of a phosphotransacetylase from Bacillus subtilis and its complex with acetyl phosphate. J Struct Funct Genomics (2005) 0.80
Spontaneous regression of a large hepatocellular carcinoma: case report. Ger Med Sci (2011) 0.80
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Transplantation (2007) 0.80
NMR characterization of copper and lipid interactions of the C2B domain of synaptotagmin I-relevance to the non-classical secretion of the human acidic fibroblast growth factor (hFGF-1). Biochim Biophys Acta (2009) 0.79
Hebbian errors in learning: an analysis using the Oja model. J Theor Biol (2009) 0.79
Do older patients utilize excess health care resources after liver transplantation? Ann Hepatol (2011) 0.79
Intermittent hepatic inflow occlusion during partial hepatectomy for hepatocellular carcinoma does not shorten overall survival or increase the likelihood of tumor recurrence. Medicine (Baltimore) (2014) 0.79
Lobular capillary hemangioma of the liver. Hepatobiliary Pancreat Dis Int (2009) 0.78
Utilization profile of the trauma intensive care unit at the Role 3 Multinational Medical Unit at Kandahar Airfield between May 1 and Oct. 15, 2009. Can J Surg (2011) 0.78
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients. Clin Gastroenterol Hepatol (2008) 0.78
Reduction of liver ischemia reperfusion injury by silencing of TNF-α gene with shRNA. J Surg Res (2011) 0.78
Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations. World J Gastroenterol (2011) 0.78
Increased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C post-liver transplantation increases sustained virologic response: a retrospective review. Saudi J Gastroenterol (2013) 0.78
Liver transplantation for alcoholic liver disease among Canadian transplant centres: a national study. Can J Gastroenterol (2013) 0.78
Wait times for diagnostic colonoscopy among outpatients with colorectal cancer: a comparison with Canadian Association of Gastroenterology targets. Can J Gastroenterol (2012) 0.78
Structural genomics of minimal organisms: pipeline and results. Methods Mol Biol (2008) 0.77
The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2013) 0.77
Comparison of short- and long-term outcomes after early versus late liver retransplantation: a single-center experience. J Surg Res (2013) 0.77
Kidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre. Can J Surg (2010) 0.76
Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutation. Can J Gastroenterol (2012) 0.76
Early treatment response predicts the need for liver transplantation in autoimmune hepatitis. Liver Int (2005) 0.76
Changing donor characteristics in liver transplantation over the last 10 years in Canada. Liver Transpl (2013) 0.76
Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts. Hepatobiliary Pancreat Dis Int (2012) 0.76
Predictors of belief that genetic test information about hemochromatosis should be shared with family members. Genet Test (2006) 0.76
The long-term survival of baboon-to-monkey kidney and liver xenografts. Xenotransplantation (2003) 0.76